Anesthesiology Doctors in Statesboro, GA Accepting Medicare

3 Anesthesiology doctors found. Showing 1 - 3

Dr. Justin Lee Rountree, MD Anesthesiology - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1497 Fair Rd Ste 206, Statesboro, GA 30458 Phone: 912-486-1141    Fax: 912-871-2483

Michael D Dykes, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1601 Fair Rd Ste 800, Statesboro, GA 30458 Phone: 800-827-6536    Fax: 912-644-5260

Albert Ilsun Lee, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1497 Fair Rd, Suite 206, Statesboro, GA 30458 Phone: 912-871-5951    Fax: 912-871-2483

News Archive

3M Health Information Systems releases ICD-10 Code Translation Tool

3M Health Information Systems, an international leader in ICD-9 and ICD-10 coding and clinical terminology management, has released the 3M ICD-10 Code Translation Tool, now fully integrated with 3M's medical vocabulary server, the 3M Healthcare Data Dictionary, to provide a single source solution for translating and converting ICD-9 based applications to ICD-10.

Decision Resources: Neuropathic pain drug market to be $9.7B in 2018

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the neuropathic pain drug market - driven by the launches of several novel therapies - will increase from $6 billion in 2008 to $9.7 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

MD Anderson Cancer Center and Nanobiotix collaborate to expand clinical development of NBTXR3

The University of Texas MD Anderson Cancer Center and Nanobiotix today announced a large-scale, comprehensive clinical research collaboration to evaluate innovative strategies for treating patients with head and neck, pancreatic, thoracic, lung, gastrointestinal and genitourinary cancers, with the first trials to be launched in 2019.

Scientific/technical review for XIAFLEX' European MAA commences

BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that its partner Auxilium Pharmaceuticals, Inc. announced that Pfizer Inc. received notification from the European Medicines Agency that the Marketing and Authorization Application (MAA) for XIAFLEX™ for the treatment of Dupuytren's disease (a debilitating disorder resulting from excessive collagen deposition that causes contractures of the fingers) has completed the validation phase successfully and that the scientific/technical review procedure commenced today.

Read more Medical News

› Verified 7 days ago